Answers are grounded in this paper and cite their sources.
Rescoring docked ligands with molecular dynamics (MD) and end point free energy methods such as MM/GBSA is widely used, but its benefit over docking for series of close analogs is uncertain. We compared AutoDock Vina scores with Md based MM/GBSA energies for 29 neutral p38α kinase inhibitors (PDB 3FLY) from the Open Force Field protein-ligand benchmark, whose IC50 values from a single publication span 3.8 kcal/mol in estimate ΔG. Each ligand was docked with three random seeds and simulated in two independent 20 ns replicas started from the benchmark pose (AMBER99SB-ILDN, GAFF2, TIP3L; GROMACS). MM/GBSA energies were calculated from 251 frames per trajectory without an entropy term. All 58 simulations remained stable with the ligand bound. Vina scores correlated weakly with experimental ΔG (Spearman ρ = 0.28 98% CI -0.15 to 0.62), as did replica averaged MM/GBSA energies (ρ = 0.24 -0.18 to 0.62). The difference was -0.03 (-0.50 to 0.43), so the methods were not distinguishable. Independent replicas of the same ligand differed by 3.3 kcal/mol on average, comparable to the experimental range. Raising the interior dielectric constant from 1 to 2 gave a nearly identical ranking (ρ = 0.96 between the two sets of scores; ρ = 0.37 against experiment, -0.04 to 0.69). In an exploratory analysis, ligands size alone correlated with affinity (ρ = 0.60, 0.28 to 0.82), whereas neither computed score tracked size. For this narrow range series, short MD rescoring gave no measurable improvement over docking, and replica variability limited its resolution.
No takes yet. Share an insight, caveat, or question.
Dhakal et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: